Jon Garfield
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jon Garfield
Jon Garfield is recorded as CEO at Onconetix, Inc. (ONCO). Onconetix, Inc. reported in an 8-K filed October 10, 2023 that Jon Garfield resigned as Chief Financial Officer, effective October 4, 2023. The proxy statement of Onconetix, Inc. reports total compensation of $492,542 for Jon Garfield in fiscal 2023, including a base salary of $343,167. Disclosed compensation is on record for 3 fiscal years.
“Effective as of October 4, 2023, Jon Garfield resigned as Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-16–present
-
2021-01-01–2023-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Onconetix, Inc.
Other people whose current roles at this company are on record from its filings.
- David White CEO
- Dr. Ralph Schiess CEO
- Neil Campbell CEO, Board Member
- Neil J. Campbell CEO, Board Member
- James Sapirstein Chairman, Board Member
- Sammy Dorf Chairman, Board Member
- Bruce Harmon CFO
- Karina Fedasz CFO
- Ajit Singh Board Member
- Andrew Oakley Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Onconetix, Inc. (ONCO) | Former Chief Financial Officer | $343,167 | $492,542 |
| 2022 | Onconetix, Inc. (ONCO) | Former Chief Financial Officer | $369,750 | $903,059 |
| 2021 | Onconetix, Inc. (ONCO) | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.